tweenvest

Clywedog Therapeutics, Inc. (NasdaqCM: CLYD)

Health Care · Biotechnology · US

—

— today · — 1Y

Public summary
A free snapshot of Clywedog Therapeutics, Inc., with figures as of Nov 15, 2026. The full analysis is in the app.Open in the app

Clywedog Therapeutics, Inc. (NasdaqCM: CLYD) operates in the Biotechnology industry within the Health Care sector.

Tweenvest scores Clywedog Therapeutics, Inc. across four factors: quality 38/100. Its strongest factor is quality.

CLYD price history

Not enough price history to draw a chart yet.

Key figures

Market cap
—
Revenue (TTM)
—
P/E
—
EPS
-11.25
Dividend yield
—
Beta (5Y)
—
52-week high
—
52-week low
—
Avg volume (3M)
—
Shares outstanding
—
Employees
—
Next earnings
—
CompanyMarket capPriceDay
Rebus Holdings, Inc.OTCPK: RBSH$32.00$0.00-99.00%
HAVN Life Sciences Inc.OTCPK: HAVL.F$29.00$0.000.00%
TetraLogic Pharmaceuticals CorporationOTCPK: TLOG$24.00$0.00-99.00%
IMV Inc.OTCPK: IMVI.F$15.00$0.00-99.00%
PhaseRx, Inc.OTCPK: PZRX.Q$12.00$0.000.00%
ContraFect CorporationOTCPK: CFRX.Q$11.00$0.000.00%
Notable Labs, Ltd.OTCPK: NTBL.Q$10.00$0.000.00%
OncoSec Medical IncorporatedOTCPK: ONCS.Q$6.00$0.000.00%

Browse every Biotechnology company →